In adenomas, the KRAS c.34G>T mutation was present in 6/9 (66.7 %) and 2/27 (7.4 %) of the biallelic MUTYH and non-hereditary adenomas, respectively (p-value=3.1 × 10–2). This evidence concerns the gene KRAS and adenoma.